Key insights
- Insperity's stock declined due to rising benefit costs outpacing pricing, leading to margin compression. Insider buying suggests potential undervaluation. While not a broad market indicator, weakness in companies sensitive to labor costs and benefits could signal broader economic pressures.
Insperity (NSP) stock has crashed to new lows on what looks like temporary problems than a permanent breakdown of its value thesis. Recently, I have observed a spate of insider buying by execs at 10-year lows.
Insperity’s core value proposition is to help small and mid-sized businesses outsource the complexity of HR so they can focus on running and growing their core business. It bundles payroll, benefits, compliance, HR support, and talent-related services into one relationship, which reduces administrative burden and can give smaller firms access to capabilities they could not easily build in-house.
In practical terms, customers buy Insperity for three things: time savings, compliance support, and better employee benefits/HR infrastructure. That makes Insperity less of a pure software vendor and more of a high-touch business services partner with a people-first positioning. Insperity sells peace of mind and operating leverage to businesses that want professional HR without building and staffing a full internal HR department.
Insperity’s 2025 EPS and free cash flow per share declined mainly because benefits costs rose faster than pricing could offset them, compressing gross margin and operating profit. The company explicitly pointed to “continued elevated benefits costs,” including inpatient, outpatient, and pharmacy trends plus more large claims, as the key driver of the profit slump. A second factor was that revenue growth was not enough to protect profitability. Even though 2025 revenue was still growing, gross profit fell sharply and cash from operating activities turned negative in the reported quarter, which is consistent with margin pressure flowing through to free cash flow per share. Insperity’s model is sensitive to benefit-cost trends because it earns on managing payroll and HR services, but it also carries exposure to employee benefits economics. In short, 2025 was a margin compression year, not primarily a demand-collapse year. The company operates on thin operating margins so it does not take much to collapse the margin but subsequent price increases and improvements are not a huge deal either.
Insperity is responding with a mix of pricing, plan design changes, cost cuts, and organizational restructuring to offset elevated benefits costs. Management has said it is working on client pricing, contract changes, and plan changes with UnitedHealthcare, while also pursuing operating-cost initiatives to restore margins. I expect margins to fully recover in the next couple of years and the stock to recover as well. The stock can deliver a multi-bagger return as profit margins and multiple normalize.